Related Experiment Video

Updated: Jul 12, 2025

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers
03:37

Author Spotlight: Impact of Intergenic Interactions on Disease-Identifying Dark Biomarkers

Published on: March 1, 2024

792

Epigenetic regulation in lung cancer

Shahin Ramazi1, Maedeh Dadzadi2, Zahra Sahafnejad1

  • 1Department of Biophysics Faculty of Biological Sciences Tarbiat Modares University Tehran Iran.

Medcomm
|October 30, 2023
PubMed

Insights

Epigenetic mechanisms like DNA methylation are key drivers of lung cancer development. Targeting these epigenetic changes with drugs offers a promising strategy for effective lung cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Lung cancer remains a leading cause of cancer mortality globally.
  • Tumorigenesis is influenced by genetic, epigenetic, and environmental factors.
  • Epigenetic mechanisms, including DNA methylation (DNAm), histone modifications, and microRNA expression, are critical in lung cancer development.

Purpose of the Study:

  • To explore the role of epigenetic mechanisms in lung cancer.
  • To investigate the potential of epigenetic drugs in lung cancer treatment.
  • To highlight microRNAs and exosomes as biomarkers for lung cancer diagnosis and assessment.

Main Methods:

  • Review of studies on DNA methylation patterns in lung cancer.
  • Analysis of microRNA and exosome roles in lung cancer.
  • Examination of epigenetic drug targets and combination therapies in non-small cell lung cancer.

Main Results:

  • Aberrant DNA methylation patterns, particularly promoter hypermethylation, significantly contribute to lung cancer progression.
  • MicroRNAs and exosomes show potential as reliable biomarkers for early diagnosis and treatment monitoring.
  • Epigenetic drugs targeting aberrant modifications demonstrate therapeutic promise.
  • Combination therapy is emerging as a strategy to overcome drug resistance in lung cancer.

Conclusions:

  • Epigenetic alterations are fundamental to lung cancer pathogenesis.
  • Targeting epigenetic mechanisms with novel drugs represents a significant advancement in lung cancer therapy.
  • Further research into epigenetic drugs and combination strategies is crucial for improving patient outcomes.
Keywords:
DNA methylationWnt signaling pathwayaberrant hypermethylationepigenetic markerlung cancertumor suppressor genes

More Related Videos

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds13:34

A Combined 3D Tissue Engineered In Vitro/In Silico Lung Tumor Model for Predicting Drug Effectiveness in Specific Mutational Backgrounds

Published on: April 6, 2016

10.2K
Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma13:18

Network Pharmacology Prediction and Experimental Validation of Trichosanthes-Fritillaria thunbergii Action Mechanism Against Lung Adenocarcinoma

Published on: March 3, 2023

1.3K

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
3.0K
Genomic Imprinting and Inheritance02:30

Genomic Imprinting and Inheritance

Diploid organisms inherit genetic material through chromosomes from both parents. Copies of the same gene are known as alleles. In most cases, both alleles are simultaneously expressed and allow various cellular processes to function optimally. If one of the alleles is missing or mutated, the expression of the other allele can compensate; however, this is not true for all genes.
The expression of some genes depends on which parent passed the gene to the offspring, through a phenomenon known as...
34.6K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.8K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.9K
lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
8.6K
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K